Skip to main content
Viewing from:
Department GEZ-LTA Erasmushogeschool
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Archive
Global health
Authors
About
Help
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Archive
Global health
Authors
About
Help
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
More
You are viewing from:
Department GEZ-LTA Erasmushogeschool
You are here
Home
Archive
Volume 17, Issue 3
Eculizumab therapy and complement regulation in a case of resistant catastrophic antiphospholipid syndrome
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Case Reports: Rare disease
Eculizumab therapy and complement regulation in a case of resistant catastrophic antiphospholipid syndrome
Online download statistics by month:
Online download statistics by month: March 2024 to April 2025
Abstract
Full
Pdf
Mar 2024
1313
57
22
Apr 2024
405
21
21
May 2024
205
9
3
Jun 2024
183
8
5
Jul 2024
116
3
3
Aug 2024
162
6
5
Sep 2024
164
7
6
Oct 2024
88
7
2
Nov 2024
129
6
2
Dec 2024
108
8
8
Jan 2025
112
5
4
Feb 2025
28
6
7
Mar 2025
4
1
0
Apr 2025
4
2
4
Total
3021
146
92
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF